Table 2.
Developed biosensors for the detection of SARS-CoV-2.
| Target | Biosensors | Principle | LOD/Detection Time/Cutoff Value/Sensitivity, Specificity | Drawbacks/Targets | References |
| Genome Based Detection | Label-free electrochemical biosensor | DNA hybridization of electrodeposited AuNPs immobilized with single-stranded nucleotide | - | RNA extraction Sensitive sample handling |
[130] |
| Plasmonic biosensors (optical-LSPR) | Dual-functional plasmonic biosensor combining the plasmonic photothermal (PPT) effect and localized surface plasmon resonance (LSPR) sensing transduction | 0.22 pmol/L, 3 min | From multigene mixture | [131] | |
| Naked-eye colorimetric | Thiol-modified antisense oligonucleotide is used to cap AuNPs, which change color upon finding the target N-gene | 0.18 ng/μL, 10 min |
N-gene | [132] | |
| Viral Particle Based Detection | Cell-based biosensor | Membrane-engineered mammalian cell containing antibody to bind with S-antigen | 1 fg/mL, 3 min |
Not applicable for the detection of variants. | [133] |
| Nanoplasmonic sensors | Optical measurement of the SARS-CoV-2 particle | 370 vp/mL, 15 min |
Restricted for the S-antigen | [134] | |
| Field effect-based transistor | Graphene-coated sheets with SARS-CoV-2 antibody | 2.42 × 102 copies/mL (in clinical samples) | s-antigen | [135] | |
| G-druplex-based biosensors | Whole genome | [136] | |||
| Molecularly imprinted polymers | Monoclonal-type, synthetic antibodies of SARS-CoV-2 | - | Only applied to the S-antigen | [137] | |
| eCovSens | Potentiostat-based sensor fluorine doped tin oxide + AuNPs immobilized with monoclonal antibody | 90 fmol/L, 10–30 s |
S-antigen | [138] | |
| Electrochemical Biosensor | Functionalized TiO2 nanotube-based electrochemical | 0.7 nmol/L, 30 s |
S-glycoprotein | [139] | |
| Lateral flow immunoassay | ACE2 enzyme binding captured antibody | 1.86 × 105 copies/mL | Spike antigen | [140] | |
| Antibody Based Detection | Lateral flow immunoassay | Lanthanide-doped Nanoparticles | 0.06666, 10 min |
Anti-SARS-CoV-2-IgG | [141] |
| Immunochromatographic | 15 min, 85.2% and 100% |
IgG-IgM combined | [142] | ||
| Immobilization on AuNPs | 15 min, 88.66% and 90.63% | IgG-IgM combined | [40] | ||
| Plasmon-enhanced biosensor | Grating Coupled Fluorescent Plasmonic (GC-FP) based on ELISA from dried blood spot samples | 30 min 100% and 100% |
Multiplexed (IgG, IgM, IgA) | [143] | |
| Opto-microfluidic | A microfluidic device fabricated by the electrodeposition of Au-nanospikes linked with the optic probe to detect the target by using localized surface plasmon resonance | 0.5 pmol/L, 30 min |
Antibodies against the spike protein | [144] |